Taipei, Saturday, August 19, 2017 17:29 (GMT+8)
thunderstorms
Taipei
34°C
Taiwan PCB makers ramping up capacity - related company info
Ingrid Lee, Taipei; Steve Shen, DIGITIMES [Monday 19 November 2012]
  • APEX Medical
  • Performance
    The company's stock price closed at NT$29.1 on the TSE on Thursday, August 17, 2017.
    The company has reported consolidated revenues of NT$188 million for July 2017, representing a 6.4% increase on month and 34.3% increase on year.
    For the second quarter of 2017, the company totaled NT$542 million in consolidated revenues, up 15.6% sequentially and up 3% on year.
    Brief

    Full name: APEX Medical

    Chinese name: 雃博股份有限公司

    Short name: Apex

    Stock code: 4106

    Tax ID: 23632773

    Market: TSE

    Established: 17 Mar 1990

    Paid in capital: NT$833.86 million

    Listed on TSE: 8 Nov 2004

    Listed on OTC: 22 Jan 2002

    Listed on ESB: 2 Jan 2002

    Public since: 19 Jul 1999

    Website: cht.apexmedical.com.tw

  • Latest stock
    Apex [4106] historical stock price (NT$)
    DateVolume (k)TransactionsValueOpenHighLowCloseChangeAskBid
    18-Aug 166 133 4,907,359 29.10 29.80 29.10 29.65+0.55+1.89% 29.65 29.70
    17-Aug 102 65 2,972,750 29.05 29.30 29.05 29.10+0.05+0.17% 29.10 29.20
    16-Aug 94 58 2,741,150 29.30 29.30 29.00 29.05-0.05-0.17% 29.05 29.10
    15-Aug 117 76 3,396,479 29.05 29.15 28.80 29.10+0.25+0.87% 28.85 29.10
    14-Aug 116 71 3,372,650 29.00 29.20 28.80 28.85-0.20-0.69% 28.85 29.00
    11-Aug 111 84 3,243,629 29.60 29.60 29.05 29.05+0.25+0.87% 29.05 29.20
    10-Aug 193 136 5,597,494 29.30 29.30 28.80 28.80-0.50-1.71% 28.80 28.95
    • Source: TSE, compiled by Digitimes
    Latest sales

    Apex: Consolidated revenues, Jul 2016 - Jul 2017 (NT$m)

    Month

    Sales

    M/M

    Y/Y

    YTD

    Y/Y

    Jul-17

    188

    6.4%

    34.3%

    1,199

    2.1%

    Jun-17

    176

    (11.9%)

    1%

    1,011

    (2.3%)

    May-17

    200

    20.9%

    16.4%

    835

    (2.9%)

    Apr-17

    166

    (17.5%)

    (7.7%)

    635

    (7.8%)

    Mar-17

    201

    46.7%

    13.5%

    469

    (7.8%)

    Feb-17

    137

    4.2%

    1.5%

    268

    (19.1%)

    Jan-17

    131

    (35%)

    (33.2%)

    131

    (33.2%)

    Dec-16

    202

    21.6%

    2.1%

    1,989

    (1.4%)

    Nov-16

    166

    6.6%

    2.8%

    1,787

    (1.8%)

    Oct-16

    156

    13.8%

    (8.4%)

    1,621

    (2.3%)

    Sep-16

    137

    (10.3%)

    (7%)

    1,465

    (1.5%)

    Aug-16

    153

    9.2%

    15.7%

    1,327

    (1%)

    Jul-16

    140

    (20%)

    (0.7%)

    1,175

    (2.8%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, August 2017

    Apex: Consolidated revenues, 2Q16 - 2Q17 (NT$m)

    Quarter

    Sales

    Q/Q

    Y/Y

    YTD

    Y/Y

    2Q-17

    542

    15.6%

    3%

    1,011

    (2.3%)

    1Q-17

    469

    (10.8%)

    (7.8%)

    469

    (7.8%)

    4Q-16

    526

    22.4%

    (0.8%)

    1,990

    (1.3%)

    3Q-16

    430

    (18.4%)

    2.8%

    1,465

    (1.5%)

    2Q-16

    526

    3.5%

    (4.5%)

    1,035

    (3.1%)

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, August 2017

    Latest balance sheet and income statement

    Apex: Consolidated balance sheet, 2Q16 - 2Q17 (NT$k)

    Item

    2Q-2017

    1Q-2017

    4Q-2016

    3Q-2016

    2Q-2016

    Current assets

    1,338,039

    1,233,710

    1,268,131

    1,108,550

    1,192,820

    Intangible assets

    420,386

    415,497

    432,513

    445,656

    467,711

    Non-current assets

    1,317,025

    1,273,566

    1,322,918

    1,318,301

    1,360,602

    Assets

    2,655,064

    2,507,276

    2,591,049

    2,426,851

    2,553,422

    Current liabilities

    804,349

    678,421

    738,224

    869,126

    967,005

    Non-current liabilities

    296,389

    295,241

    294,782

    5,427

    5,479

    Liabilities

    1,100,738

    973,662

    1,033,006

    874,553

    972,484

    Stockholders' equity

    1,554,326

    1,533,614

    1,558,043

    1,552,298

    1,580,938

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, August 2017

    Apex: Consolidated income statement, 2Q16 - 2Q17 (NT$k)

    Item

    2Q-2017

    1Q-2017

    4Q-2016

    3Q-2016

    2Q-2016

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    NT$k

    % of sales

    Gross sales

     

     

    469,035

     

    0

     

     

     

     

     

    Operating revenue

    542,086

    115.6%

    469,035

    100%

    525,757

     

    429,703

    79.3%

    526,243

    97.1%

    Gross profit (loss) from operations

    246,958

    52.7%

    211,420

    45.1%

    217,533

    41.4%

    192,185

    35.5%

    240,584

    44.4%

    Operating expenses

    182,293

    38.9%

    170,935

    36.4%

    188,896

    35.9%

    167,287

    30.9%

    190,327

    35.1%

    Operating income (loss)

    64,665

    13.8%

    40,485

    8.6%

    28,637

    5.4%

    24,898

    4.6%

    50,257

    9.3%

    Non-operating expenses and losses

    -3,328

    -0.7%

    -3,882

    -0.8%

    -8,381

    -1.6%

    3,988

    0.7%

    2,769

    0.5%

    Income from continuing operations before income tax

    61,337

    13.1%

    36,603

    7.8%

    20,256

    3.9%

    28,886

    5.3%

    53,026

    9.8%

    Net income (loss)

    48,498

    10.3%

    26,213

    5.6%

    15,624

    3%

    26,264

    4.8%

    33,766

    6.2%

    Diluted earnings per share (NT$)

    0.5

     

    0.3

     

    0.2

     

    0.3

     

    0.4

     

    *Figures are consolidated
    Source: TSE, compiled by Digitimes, August 2017

  • APEX Medical full profile

18-Aug-2017 markets closed

 LastChange

TAIEX (TSE)10321.33-48.04-0.46% 

TSE electronic437.42-2.43-0.55% 

GTSM (OTC)135.34-0.13-0.1% 

OTC electronic197.77-0.04-0.02% 

Global notebook shipment forecast, 2017 and beyond
China AMOLED panel capacity expansion forecast, 2016-2020
Global notebook shipment forecast, 2017 and beyond
  • The 10nm competition

    TSMC and Samsung have been competing for clients for the 10nm node.

  • Memory price rally

    DRAM prices have been rising amid tight supply.

  • ASE-SPIL merger

    A proposed merger between Advanced Semiconductor Engineering (ASE) and Siliconware Precision Industries (SPIL) has yet to receive approval from the US...

  • Japan earthquake

    Earthquakes in Japan often cause huge damage. They have had strong impacts on the country's electronics industry.

  • China AMOLED panel capacity expansion forecast, 2016-2020

    This Digitimes Research Special Report examines the China AMOLED industry, focusing on the expansion capacity of the makers, the current implementation plans of major smartphone vendors in the market and the technological hurdles faced by the China makers.

  • Global AP demand forecast, 2017-2020

    Digitimes Research expects global AP shipments to surpass the 1.9 billion mark in 2017, with smartphones remaining the main application. Qualcomm will be leading the market in 2017, as other players continue playing catch up and scramble for funds to invest in more diverse applications.

  • Global notebook shipment forecast, 2017 and beyond

    This Digitimes Special Report examines key factors in the notebook industry, including products, vendors and ODMs, that will affect total shipments in 2017 and through 2021.